PL2435028T3 - Uszczelniacz fibrynowy w postaci suchego proszku - Google Patents

Uszczelniacz fibrynowy w postaci suchego proszku

Info

Publication number
PL2435028T3
PL2435028T3 PL10720628T PL10720628T PL2435028T3 PL 2435028 T3 PL2435028 T3 PL 2435028T3 PL 10720628 T PL10720628 T PL 10720628T PL 10720628 T PL10720628 T PL 10720628T PL 2435028 T3 PL2435028 T3 PL 2435028T3
Authority
PL
Poland
Prior art keywords
dry powder
fibrin sealant
powder fibrin
sealant
dry
Prior art date
Application number
PL10720628T
Other languages
English (en)
Inventor
Glen Patrick Martyn
Jacob Koopman
Original Assignee
Profibrix Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43012499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2435028(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0909138.0A external-priority patent/GB0909138D0/en
Priority claimed from GBGB0909137.2A external-priority patent/GB0909137D0/en
Application filed by Profibrix Bv filed Critical Profibrix Bv
Publication of PL2435028T3 publication Critical patent/PL2435028T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
PL10720628T 2009-05-28 2010-05-28 Uszczelniacz fibrynowy w postaci suchego proszku PL2435028T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0909138.0A GB0909138D0 (en) 2009-05-28 2009-05-28 Dry powder fibrin sealant
GBGB0909137.2A GB0909137D0 (en) 2009-05-28 2009-05-28 Dry power fibrin sealant

Publications (1)

Publication Number Publication Date
PL2435028T3 true PL2435028T3 (pl) 2017-09-29

Family

ID=43012499

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10720628T PL2435028T3 (pl) 2009-05-28 2010-05-28 Uszczelniacz fibrynowy w postaci suchego proszku

Country Status (9)

Country Link
US (1) US9119897B2 (pl)
EP (1) EP2435028B1 (pl)
JP (1) JP5820807B2 (pl)
CN (1) CN102448443A (pl)
AU (1) AU2010252929B2 (pl)
CA (1) CA2761903C (pl)
ES (1) ES2593584T3 (pl)
PL (1) PL2435028T3 (pl)
WO (1) WO2010136588A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
KR20120125465A (ko) * 2010-01-08 2012-11-15 프로피브릭스 비.브이. 건조 분말 피브린 실란트
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof
US20160015792A1 (en) * 2013-03-07 2016-01-21 Profibrix Bv Powder formulation comprising thrombin and fibrinogen
US10772767B2 (en) 2013-06-28 2020-09-15 3M Innovative Properties Company Fibrin-coated wound dressing
KR101864465B1 (ko) * 2014-01-21 2018-06-04 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 의료용 도관을 통한 생체 내 투여성 마이크로 입자
CN112807482B (zh) * 2018-08-20 2022-07-29 稳得希林(杭州)生物科技有限公司 多糖基组织粘合医用胶及其应用
KR20210052099A (ko) * 2019-10-31 2021-05-10 주식회사 삼양바이오팜 분말형 지혈제 조성물 및 이의 제조 방법

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE13810T1 (de) * 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
JP2948254B2 (ja) 1990-03-06 1999-09-13 ユニチカ株式会社 癒着防止材
US7196054B1 (en) * 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
NZ292980A (en) * 1994-09-29 1999-02-25 Andaris Ltd Smooth, spherical water-soluble microparticles as therapeutic or diagnostic vehicles
GB9423419D0 (en) 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5702715A (en) * 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
WO1997044015A1 (en) * 1996-05-17 1997-11-27 Andaris Limited Microparticles and their use in wound therapy
ES2232862T3 (es) 1996-10-21 2005-06-01 Quadrant Drug Delivery Limited Sustitutos de plaquetas y procedimientos de conjugacion apropiados para su preparacion.
EP1056484A1 (en) 1998-02-20 2000-12-06 Quadrant Healthcare (UK) Limited Products comprising fibrinogen for use in therapy
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
DE19849589C1 (de) * 1998-10-27 2000-06-15 Glatt Process Technology Gmbh Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung
DE10025001A1 (de) * 2000-05-22 2001-11-29 Aventis Behring Gmbh Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften
US7572769B2 (en) 1998-12-23 2009-08-11 Csl Behring Gmbh Fibrin adhesive granulate and method for its preparation
DE19859611C2 (de) 1998-12-23 2003-07-03 Aventis Behring Gmbh Fibrinklebergranulat und Verfahren zu dessen Herstellung
GB2355711B (en) * 1999-10-27 2003-12-24 Agilent Technologies Inc Porous silica microsphere scavengers
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
CN1364889A (zh) 2001-01-10 2002-08-21 上海博德基因开发有限公司 一种新的多肽——人周期蛋白依赖激酶16.82 和编码这种多肽的多核苷酸
DE60227691D1 (de) * 2001-11-01 2008-08-28 Nektar Therapeutics Sprühtrocknungsverfahren
IL162369A0 (en) * 2001-12-04 2005-11-20 Woolverton Christopher J Storage-stable fibrin sealant
AU2002361902A1 (en) 2001-12-31 2003-07-24 Ares Medical, Inc. Hemostatic compositions and methods for controlling bleeding
US7544177B2 (en) 2002-01-24 2009-06-09 The Regents Of The University Of California Aerosol device to deliver bioactive agent
CN1327905C (zh) 2002-09-10 2007-07-25 美国国家红十字会 止血敷料
AU2003282356A1 (en) * 2002-11-20 2004-06-15 Bar-Ilan University Biological glue based on thrombin-conjugated nanoparticles
CN1454667A (zh) * 2003-05-07 2003-11-12 徐振彪 使用方便的纤维蛋白封闭剂
US20050123588A1 (en) 2003-06-16 2005-06-09 Zhu Yong H. Deployable multifunctional hemostatic agent
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20060019868A1 (en) * 2004-01-30 2006-01-26 Pendharkar Sanyog M Hemostatic compositions and devices
US8403923B2 (en) * 2004-10-29 2013-03-26 Spinal Restoration, Inc. Injection of fibrin sealant in the absence of corticosteroids in spinal applications
JP2008507362A (ja) * 2004-07-22 2008-03-13 ヘモ ナノサイエンス リミテッド ライアビリティ カンパニー 過剰な出血を処置するための組成物および方法
CA2576424C (en) 2004-08-19 2013-05-07 Tyco Healthcare Group Lp Water-swellable copolymers and articles and coatings made therefrom
US20060155235A1 (en) * 2004-12-17 2006-07-13 Sawyer Evelyn S Hemostatic compression bandage
MY142987A (en) 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
US20070087061A1 (en) 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
US20070248653A1 (en) 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
WO2007127841A2 (en) * 2006-04-26 2007-11-08 Arteriocyte Medical Systems, Inc. Compositions and methods of preparation thereof
DK2021043T3 (da) * 2006-05-26 2011-04-04 Baxter Int Injicerbart fyldstof til knoglehulrum
BRPI0712910B8 (pt) * 2006-05-26 2021-05-25 Baxter Int sistema de múltiplos componentes para uma composição de aumento ósseo injetável, e, composição de aumento ósseo injetável
NZ574653A (en) * 2006-08-04 2012-11-30 Stb Lifesaving Technologies Inc Solid dressing for treating wounded tissue
US20090148502A1 (en) * 2006-10-23 2009-06-11 Hemo Nanoscience, Llc Compositions and methods for treating lacerations, abrasions, avulsions, burns, ulcers, and cases of excessive bleeding
DK2136852T3 (da) * 2007-03-26 2012-04-16 Baxter Int Injicerbart hulrumsfyldstof til forøgelse af blødt væv
US8821861B2 (en) 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2010002435A2 (en) 2008-07-03 2010-01-07 Kulinets Irina B Hemostatic pouch and method to stabilize hemostatic components
GB0909136D0 (en) * 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition

Also Published As

Publication number Publication date
EP2435028A2 (en) 2012-04-04
US20120070477A1 (en) 2012-03-22
EP2435028B1 (en) 2016-08-31
WO2010136588A3 (en) 2011-04-21
JP5820807B2 (ja) 2015-11-24
WO2010136588A2 (en) 2010-12-02
CA2761903C (en) 2018-04-10
AU2010252929A1 (en) 2011-12-08
ES2593584T3 (es) 2016-12-09
CN102448443A (zh) 2012-05-09
AU2010252929B2 (en) 2015-08-27
US9119897B2 (en) 2015-09-01
JP2012527924A (ja) 2012-11-12
CA2761903A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
IL220832A (en) Fibrin seals with dry powder
PL2529134T3 (pl) Układ uszczelnienia obrotowego
PL2435028T3 (pl) Uszczelniacz fibrynowy w postaci suchego proszku
PL2459906T3 (pl) Zespół uszczelniający
GB0908751D0 (en) Slot seal
GB0815778D0 (en) Seal
GB0907667D0 (en) Seal
GB201015582D0 (en) Improved materials
EP2455437A4 (en) SEALING MATERIAL
EP2444672A4 (en) ROTARY COMPRESSOR
GB201001834D0 (en) Bridging seal
GB0800884D0 (en) Improved seal
PL2563680T3 (pl) Uszczelnienie
GB0909136D0 (en) Dry powder composition
GB2478918B (en) Interstage seal
EP2418386A4 (en) ROTARY COMPRESSOR
GB0909131D0 (en) Dry powder fibrin sealant
GB0917317D0 (en) Rotary structures
GB0909129D0 (en) Dry powder fibrin sealant
EP2407290A4 (en) SEALED MIXER
GB0909138D0 (en) Dry powder fibrin sealant
GB2475879B (en) Seal
GB201120986D0 (en) Seal
GB0909137D0 (en) Dry power fibrin sealant
GB0809539D0 (en) Rotary seal